HDMA elects new directors to its board
Attain Med, Inc., KeySource Medical, and TopRx now represented in HDMA leadership
At its annual Business and Leadership Conference (Orlando, FL), HDMA elected three new members to its board:
Scott Franklin, president, TopRx, Inc. (Bartlett, TN)
Lenny Rodriguez, CEO, Attain Med, Inc. (Atlanta)
R. Todd Szewc, CFO, KeySource Medical (Cincinnati)
John Gray, HDMA president, commented that the new directors bring “distinctive new voices to our Board;” he might have been referring to the fact that the companies represented by these directors put an emphasis either on generics-only distribution or on serving independent pharmacies—or both. In recent years, HDMA has emphasized that it represents “full line” distributors (i.e., most types of branded or generic pharmacueticals, to most types of dispensing customers). Even so, it is true that over 80% of all pharmaceuticals distributed in the US are generic, and that independent pharmacies (especially in the aftermath of the AmerisourceBergen-Walgreens-Alliance Boots linkage) are hotly contested as customers by the Big Three wholesalers and most other HDMA members.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
